Floatz logo

Ketoconazole

Anatomic Stage IV Breast Cancer AJCC v8

Wake Forest University Health SciencesPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

891 Active assets in the Anatomic Stage IV Breast Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Lapatinib
University of New Mexico
Phase 3BBB
Darolutamide
Vandana Abramson
Phase 2BBB
Trastuzumab Duocarmazine
Byondis B.V.
Phase 3BB
TAMOXIFEN
Dana-Farber Cancer Institute
Phase 4BB
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
SWOG Cancer Research Network
Phase 4BB

View all 50 →

Same molecule, other indications

Ketoconazole is also rated in:

prostate cancerDormant
B
Indicative ·
57 / 100
View asset →
prostate adenocarcinomaDormant
CCC
Indicative ·
55 / 100
View asset →
prostate neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →